
Gyre Therapeutics Inc
NASDAQ:GYRE

Intrinsic Value
The intrinsic value of one
GYRE
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 8.4 USD,
Gyre Therapeutics Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Gyre Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Gyre Therapeutics Inc
Balance Sheet Decomposition
Gyre Therapeutics Inc
Current Assets | 64.8m |
Cash & Short-Term Investments | 26.7m |
Receivables | 29.2m |
Other Current Assets | 9m |
Non-Current Assets | 60.6m |
Long-Term Investments | 24.6m |
PP&E | 25.7m |
Intangibles | 273k |
Other Non-Current Assets | 10.1m |
Free Cash Flow Analysis
Gyre Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Gyre Therapeutics Inc
Revenue
|
105.8m
USD
|
Cost of Revenue
|
-3.9m
USD
|
Gross Profit
|
101.9m
USD
|
Operating Expenses
|
-85.6m
USD
|
Operating Income
|
16.2m
USD
|
Other Expenses
|
-4.1m
USD
|
Net Income
|
12.1m
USD
|
GYRE Profitability Score
Profitability Due Diligence
Gyre Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Gyre Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
GYRE Solvency Score
Solvency Due Diligence
Gyre Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Gyre Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GYRE Price Targets Summary
Gyre Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
GYRE
is 20.4 USD
with a low forecast of 20.2 USD and a high forecast of 21 USD.
Dividends
Current shareholder yield for GYRE is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GYRE
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 8.4 USD,
Gyre Therapeutics Inc
is
hidden
.